What happens during a C&P exam for Pterygium?

Do NOT stretch, warm up, or take pain medication before your exam. The VA needs your baseline limitation. Report your WORST day. DeLuca v. Brown requires documentation of functional loss during flare-ups.

← All Condition Guides

CLAIM RECON INTEL

Pterygium

Q: What are the VA rating percentages for Pterygium?

Pterygium (DC 6034) is rated at 0% under 38 CFR § 4.79, DC 6034. No standalone tier. Per DC 6034, evaluate the pterygium under (a) the General Rating Formula for active episodes, (b) disfigurement (§ 4.118 DC 7800) if cosmetically apparent, and (c) any associated chronic conjunctivitis (DC 6018) — COMBINE the resulting evaluations per § 4.25.

Q: What rates 0% for Pterygium under 38 CFR § 4.79, DC 6034?

Under 38 CFR § 4.79, DC 6034 (DC 6034), a 0% rating for Pterygium requires: No standalone tier. Per DC 6034, evaluate the pterygium under (a) the General Rating Formula for active episodes, (b) disfigurement (§ 4.118 DC 7800) if cosmetically apparent, and (c) any associated chronic conjunctivitis (DC 6018) — COMBINE the resulting evaluations per § 4.25.

Q: What evidence do I need for a Pterygium VA claim?

Key evidence for a Pterygium claim includes: Service treatment records showing injury or complaints; Imaging (X-ray, MRI, CT); Range of motion measurements; Flare-up documentation per Sharp v. Shulkin; Buddy statements describing limitations. All evidence should document both the condition and its impact on daily functioning.

DC 603438 C.F.R. § 4.79

Diagnostic Code

DC 6034

38 C.F.R. § 4.79

Rating Range

0–0%

1 severity tier

Source

Verified

38 C.F.R. § 4.79

Pterygium is rated by the U.S. Department of Veterans Affairs under DC 6034 of 38 CFR § 4.79, DC 6034 across 1 severity tier (0%). Service connection requires (1) a current diagnosis, (2) an in-service event, injury, or exposure, and (3) a medical nexus opinion linking the two under 38 C.F.R. § 3.303.

Educational tool only. Not legal or medical advice. Not affiliated with the VA.

Overview

Benign, wedge-shaped growth of the conjunctiva onto the cornea, typically from the nasal side. Associated with chronic UV light exposure, wind, and dust - all common in military service. May cause irritation, redness, and if it grows large enough, visual distortion or obstruction.

Rating Criteria

No standalone tier. Per DC 6034, evaluate the pterygium under (a) the General Rating Formula for active episodes, (b) disfigurement (§ 4.118 DC 7800) if cosmetically apparent, and (c) any associated chronic conjunctivitis (DC 6018) — COMBINE the resulting evaluations per § 4.25.

03Key Evidence

—Service treatment records showing injury or complaints

—Imaging (X-ray, MRI, CT)

—Range of motion measurements

—Flare-up documentation per Sharp v. Shulkin

—Buddy statements describing limitations

—Prescription history

—Physical therapy records

—Employment impact documentation

04C&P Exam Tips

1Do NOT stretch, warm up, or take pain medication before your exam. The VA needs your baseline limitation.

2Report your WORST day. DeLuca v. Brown requires documentation of functional loss during flare-ups.

3Tell the examiner about flare-ups: frequency, duration, estimated ROM loss. Sharp v. Shulkin (2017) requires estimates.

4Request active, passive, weight-bearing, and non-weight-bearing ROM testing per Correia v. McDonald (2016).

5If you use assistive devices (brace, cane), bring them.

6Describe daily activity impact: work, sleep, household tasks.

Tools

Rating Calculator →Secondaries Explorer →C&P Exam Prep →PACT Act Scanner →2026 Rates →

Sources & Editorial

Rating criteria text quoted verbatim from 38 C.F.R. § 4.79 (Eye). Source verified 2026-05-17 by ClaimRecon Editorial Team against the Cornell Law CFR mirror; eCFR.gov is the authoritative government source.

View § 4.79 on eCFR →Cornell Law mirror →Editorial Standards →Suggest a correction →

EDUCATIONAL TOOL ONLY. NOT LEGAL OR MEDICAL ADVICE.
NOT AFFILIATED WITH THE U.S. DEPARTMENT OF VETERANS AFFAIRS.
CLAIM RECON 2026

LOADING